Literature DB >> 10229837

USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.

M Moriuchi1, H Moriuchi, D M Margolis, A S Fauci.   

Abstract

Transcription factors USF1 and USF2 up-regulate gene expression (i.e. , HIV-1 long terminal repeats) via interaction with an E box on their target promoters, which is also a binding site for c-Myc. The c-Myc oncoprotein is important in control of cellular proliferation and differentiation, while Yin-Yang 1 (YY1) has been shown to control the expression of a number of cellular and viral genes. These two proteins physically interact with each other and mutually inhibit their respective biological functions. In this study, we show that USF/c-Myc up-regulates, while YY1 down-regulates the promoter activity of CXCR4, a coreceptor for T cell-tropic HIV-1 entry. We have identified an E box around -260 and a YY1 binding site around -300 relative to the transcription start site. Mutation of the E box abolished USF/c-Myc-mediated up-regulation of CXCR4 promoter activity, and mutation of the YY1 binding site was associated with unresponsiveness to YY1-mediated inhibition. These data suggest that USF/c-Myc and YY1 may play an important role in the HIV-1-replicative cycle, by modulating both the viral fusion/entry process and viral expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229837

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

Review 2.  The bone marrow microenvironment and leukemia: biology and therapeutic targeting.

Authors:  Edward Allan R Sison; Patrick Brown
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

3.  The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4.

Authors:  Kathleen L Arnolds; Angela P Lares; Juliet V Spencer
Journal:  Virology       Date:  2013-03-13       Impact factor: 3.616

4.  Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription.

Authors:  Thomas D Hock; Harry S Nick; Anupam Agarwal
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

5.  Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway.

Authors:  Xiao Zhou; Xiaorui Han; Ann Wittfeldt; Jingzhi Sun; Chujun Liu; Xiaoxia Wang; Li-Ming Gan; Huiqing Cao; Zicai Liang
Journal:  RNA Biol       Date:  2016       Impact factor: 4.652

Review 6.  WHIM syndrome: congenital immune deficiency disease.

Authors:  Toshinao Kawai; Harry L Malech
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

7.  The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Authors:  Jason G Lieberthal; Marissa Kaminsky; Christopher N Parkhurst; Naoko Tanese
Journal:  Breast Cancer Res       Date:  2009-06-30       Impact factor: 6.466

8.  Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia.

Authors:  Matthew R Pawlus; Liyi Wang; Katie Ware; Cheng-Jun Hu
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

9.  An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.

Authors:  Bae-Hang Park; Sungho Kook; SeanBong Lee; Jong-Hyeon Jeong; Adam Brufsky; Byeong-Chel Lee
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

10.  Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.

Authors:  Daisuke Uchida; Tomitaro Onoue; Nasima-Mila Begum; Nobuyuki Kuribayashi; Yoshifumi Tomizuka; Tetsuya Tamatani; Hirokazu Nagai; Youji Miyamoto
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.